Verrica Pharmaceuticals
NASDAQ: VRCAWest Chester, US · Founded 2013 · Delaware corporation · 1 known investors
Publicly listed pharmaceutical company
Founders & leadership
Board
JR
PB
DZ
SS
MP
Mark PrygockiBoard director
DN
Diem NguyenBoard director
GC
Gavin CorcoranBoard director
LE
Lawrence EichenfieldBoard director
GO
Glenn OclassenBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$77.5M disclosed across 4 rounds · 2015–2025
▶$50MraisedDec 2025 · 21 investors · PharmaceuticalsRule 506(b)
▶$50MraisedDec 2025 · 21 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark PrygockiDirector
- Noah RosenbergExecutive Officer
- Diem NguyenDirector
- John KirbyExecutive Officer
- Gavin CorcoranDirector
- Jayson RiegerExecutive Officer, Director
- Paul B. ManningDirector
- David ZawitzExecutive Officer
- Lawrence EichenfieldDirector
- Sean StalfortDirector
- Offering amount
- $50M
- Amount sold
- $50M
- Sales commissions
- $500.2K
- Placement agents
- TD Securities (USA) LLC
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedFeb 2018 · 2 investors · PharmaceuticalsRule 506(b)
▶$20MraisedFeb 2018 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Glenn OclassenDirector, Promoter
- Joseph BonaccorsoExecutive Officer
- Sean StalfortDirector, Promoter
- Ted WhiteExecutive Officer
- Paul ManningDirector, Promoter
- Anthony CavalloExecutive Officer
- James C. ReebalsExecutive Officer, Promoter
- Matthew DavidsonExecutive Officer, Director, Promoter
- Jayson RiegerExecutive Officer, Director, Promoter
- Offering amount
- $21M
- Amount sold
- $20M
- Minimum investment
- $25K
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$5MraisedDec 2017 · 1 investors · PharmaceuticalsRule 506(b)
▶$5MraisedDec 2017 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sean StalfortDirector, Promoter
- Matthew DavidsonExecutive Officer, Director, Promoter
- Paul ManningExecutive Officer, Director, Promoter
- James C. ReebalsExecutive Officer, Promoter
- Jayson RiegerExecutive Officer, Director, Promoter
- Glenn OclassenDirector, Promoter
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $5M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$2.4MraisedDec 2015 · 14 investors · PharmaceuticalsRule 506(b)
▶$2.4MraisedDec 2015 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Matthew DavidsonExecutive Officer, Director
- Jayson RiegerDirector
- Glenn OclassenDirector
- Sean StalfortDirector
- Paul ManningDirector
- Amount sold
- $2.4M
- Sales commissions
- $52.5K
- Placement agents
- IMS Health Capital, Inc.
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Verrica Pharmaceuticals do?
- Publicly listed pharmaceutical company
- Who are Verrica Pharmaceuticals's investors?
- Verrica Pharmaceuticals's investors include PBM Capital.
- How much funding has Verrica Pharmaceuticals raised?
- Verrica Pharmaceuticals has disclosed $77.5M raised across 4 rounds.
- Where is Verrica Pharmaceuticals headquartered?
- Verrica Pharmaceuticals is headquartered in West Chester, US.